PERRIGO TO INTRODUCE PRIVATE-LABEL TAVIST-D
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO TO INTRODUCE PRIVATE-LABEL TAVIST-D combination antihistamine/decongestant product under an exclusive agreement with Sandoz Health Care, the Allegan, Mich.-based private-label manufacturer announced Sept. 12. Perrigo expects to begin marketing the over-the-counter product "as early as" April 1, 1995. Neither Sandoz nor Perrigo would disclose the details of the agreement.